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Abstract 
Development of a Left Heart Simulator for Prosthetic Valve Evaluation 
Gabrielle Toner 
 
 
 
 
Cardiovascular disease is the number one cause of death globally, and many valve 
diseases contribute to this statistic. Heart valve prostheses have rapidly evolved for both 
mitral and aortic designs, embodied in both mechanical and bioprosthetic designs. 
Prosthetic valves undergo extensive in vitro testing to qualify the device’s performance 
prior to clinical implantation, according to ISO 5840:1. ISO 5840:1 describes the testing 
requirements for pulse duplication, and currently, device manufacturers utilize academic 
or commercial pulse duplicators to evaluate their devices. However, both avenues have 
limitations in quality control or flexibility that bring about the need for a custom pulse 
duplicator. The objective of this research project was to develop a cardiac pulse 
duplicator to test mechanical, aortic prosthetic valves in a 3rd party pre-clinical laboratory 
and validate the benchtop system using ISO criteria. The design incorporated the use of a 
driving mechanism composed of MTS MiniBionix 858 and a bellow adapted from the 
TA Electroforce Stent Graft Tester and rigid custom housing to mimic the left ventricle, 
left atrium, and aorta, reporting pressure as the primary deliverable for analysis. The 
design was constructed and experimentally validated using criteria from ISO 5840:1, 
including aortic pressure ranges, peak diastolic differential pressure, systolic and diastolic 
ratios, motor capacity and tester repeatability. The design conformed with most criteria; 
however, further work will be needed to implement an additional dashpot component to 
decrease systolic oscillations. 

1 
Problem Statement 
Cardiac disease is the number one cause of death in the United States, accounting 
for one of every three deaths [1]. Various different cardiac diseases contribute to this 
statistic, and an estimated 85.6 million American adults have more than one type of 
cardiovascular disease (CVD) [1]. The aortic heart valve diseases, including 
regurgitation, stenosis, and genetic deformities contribute to the large degree of CVD 
incidence, partly due to the increased stress that a faulty aortic valve can place on the 
heart.  
Currently, over 290,000 surgical heart valve procedures are conducted globally 
each year, and this number is expected to increase to over 850,000 by 2050 [2]. These 
procedures include valve repair, balloon valvuloplasty, and valve replacements. Valve 
disease is initially treated with drugs; however, as the diseases become more severe, the 
patient may require valve repair or valve replacement. New, innovative prosthetic valve 
designs require testing for durability assessment and failure mode investigation. The FDA 
suggests that all valve designs undergo significant testing as specified by ISO 5840:1, 
which includes durability and pulse duplication testing. The scope of this research 
includes pulse duplication.  
Also referred to as left heart simulators (LHS), pulse duplicators are in vitro 
systems used to simulate the cardiac environment in the left heart and evaluate the 
performance of prosthetic heart valves. These systems simulate the pressures and flows 
of the cardiovascular system in a circulatory loop, allowing the valve to operate as it 
would in vivo conditions. Hence, pulse duplication testing is a strongly recommended 
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step in the process of heart valve device development for FDA submissions. The use of 
pulse duplication is vital for heart valve research because it assists in simulating how a 
valve will perform or fail in vivo, and the results of this testing directly impact R&D 
decisions made by device manufactures and the types of devices available on the market. 
Currently, existing pulse duplicators fall under two categories: research and commercial 
[3]. These two groups have advantages and disadvantages. Research pulse duplicators are 
limited by the turnover of knowledge and lack of quality control in graduate labs while 
commercial pulse duplicators are limited by their flexibility to keep up with the 
constantly advancing heart valve field and capabilities in testing new valve designs. The 
progression of prosthetic heart valve development requires the use of custom pulse 
duplicators where labs can modify systems to fit different valve needs and have 
incremental control over tuning. The use of a custom pulse duplicator for preclinical heart 
valve evaluation allows 3rd-party laboratories to standardize operating procedures, 
provide quality control, and be flexible for market needs. Building laboratory pulse 
duplicators that adhere to the criteria suggested by the FDA guidance and can conform to 
quality control structures allows effective pre-clinical assessment of these new valve 
designs, aiding in their validation. In addition, constructing a custom pulse duplicator 
allows users to broaden the capabilities of the tester and simulate pathological conditions 
for various valve types. 
  
 3 
Specific Aims 
The objective of this research study is to design a left heart simulator (LHS) to 
test mechanical, bi-leaflet, aortic valves in pulse duplication and validate the LHS using 
criteria set by ISO 5840.  
Aim I: Design of Left Heart Simulator 
There are many left heart simulators on the commercial market and in academic 
labs for evaluation of prosthetic valves [4, 5]. The use of existing commercial market 
LHSs can limit the amount of user control over modifications to the system, as these 
systems are commonly designed with a specific type of valve in mind and may not be 
adaptable to new valve designs. Academic labs offer valve testing to industry clients, but 
they can fail to maintain quality control or standard test procedures because of large 
graduate student turn over. The development of a custom pulse duplicator provides labs a 
flexible system that can be tuned to a large range of valve types and sizes. There are no 
published pulse duplicators that utilize an MTS load frame as the driving mechanism for 
pulsatile flow. This study will investigate the capability of the MTS MiniBionix 858 
actuator to simulate cardiac flow. 
The first specific aim in this study revolves is to design of a left heart simulator to 
test aortic heart valves using a novel driving mechanism. The final design will be 
optimized to test mechanical valves at physiologically relevant conditions as set by 
International Standards Organization (ISO) Standard 5840, including specified cardiac 
output, aortic pressure ranges, and testing frequencies. The design of the LHS includes a 
driving mechanism comprised of an MTS MiniBionix 858 load frame and a bellow 
adapted from the TA Electroforce Stent Graft Tester.  
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Aim II: Validation of Design 
ISO 5840 details guidelines for durability testing and pulse duplication of 
prosthetic heart valves. For pulse duplication, these criteria include, but are not limited to, 
peak diastolic differential pressure, pressure waveform shape, cardiac output ranges, 
systolic and diastolic cardiac cycle percentage, heart rate, and aortic pressure ranges. The 
ISO guidelines provide a good foundation for prosthetic valve testing; however, due to 
the growing heart valve field, the ISO guidelines are continuously changing. Therefore, 
the criteria for design validation for this study closely mimic the ISO criteria listed above, 
but general practices accepted by the research field are also included. The second specific 
aim is to validate the LHS based on its ability to achieve the ISO criteria, repeatability, 
ability to tune the system, optical clarity, valve performance and sufficient motor 
capabilities. 
 
Introduction and Background 
Cardiovascular and Valve Solutions Background 
The human heart is an organ that pumps blood throughout the body, supplying 
oxygen and nutrients to the tissues. The circulatory pathway of the blood includes 
movement through the four chambers of the heart, with its passage regulated by heart 
valves. During the cardiac cycle, the chambers passively fill (diastole) and actively push 
(systole) blood with the coordination of the four one-way heart valves. These two 
portions of the cardiac cycle, diastole and systole, rely on the timing of signals sent from 
the heart and the opening and closing of the heart valves. Heart valve activity is dictated 
by the pressure differential between the inflow and outflow side that cause the valve to 
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open or close. There are four valves that assist in blood flow: two atrioventricular valves 
and two semilunar valves. 
The results of the coordination of ventricle contraction and heart valve function 
can be explained through cardiac output and stroke volume. Cardiac output is the volume 
of blood ejected by the left ventricle over time, usually reported in L/min. Cardiac output 
can be measured using a flowmeter or calculated based on Equation 1. ISO 5840 defines 
the normal range for human cardiac output to be 2-7 L/min; however, this will increase 
greatly during exercise [6]. Stroke volume is the volume of blood ejected by the left 
ventricle in one contraction, usually reported in mL [6]. A typical stroke volume for the 
left ventricle is 70 mL. The aortic valve can be visualized in a schematic found in Figure 
1. 
 
 
 
Equation 1. Formula for calculating cardiac output, usually reported in L/min [6]. The stroke volume is the 
amount of blood ejected by the left ventricle in one contraction, measured in mL. Heart rate is the amount 
of times the heart beats per minute. 𝐶𝑎𝑟𝑑𝑖𝑎𝑐	  𝑜𝑢𝑡𝑝𝑢𝑡 = 𝑠𝑡𝑟𝑜𝑘𝑒	  𝑣𝑜𝑙𝑢𝑚𝑒	  𝑥	  ℎ𝑒𝑎𝑟𝑡	  𝑟𝑎𝑡𝑒 
 
 
 
The left ventricle of the heart is the blood pump for the entire body. The pathway 
of the blood once it leaves the left side of the heart, travels through the body, and arrives 
back at the right side of the heart can be seen in Figure 2. 
 
 
 
 
Figure 1. Schematic of the heart with focus on the placement of the aortic heart valve as well as a depiction 
of its open and closed states [7]. 
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The left side of the heart encapsulates both the mitral and the aortic valves, and 
the right side of the heart is home to the pulmonary and tricuspid valves. The left 
ventricle is more muscular and has thicker walls than the right side of the heart, giving it 
more power to pump blood through the body. The left heart is subjected to larger loads 
than the right side of the heart, leading to an increase in valve failures.  
The aortic heart valve is a semilunar valve that acts like a one-way door, allowing 
forward flow from the left ventricle to the aorta but preventing significant retrograde flow 
as seen in Figure 3. The three leaflets of the aortic heart valve are attached to fibrous 
tissue called the annulus that provide the valve with its structure The aortic root is 
composed of the aortic valve’s leaflets, leaflet attachments, annulus, sinus, and other 
components [8]. The aortic valve and its leaflets are housed in the aortic sinus, a 
widening of the aorta just past the aortic valve, in between the aorta and the valve 
leaflets. 
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Figure 2. Circulatory pathway of blood in the body. 
 
 
 
During diastole, the left ventricle fills through the mitral valve, initially filling 
about 70-80% of its capacity. Right atrium contraction fills the rest of the left ventricle, 
and the mitral valve closes to prevent retrograde flow. During systole, when the ventricle 
contracts, the pressure rises in the left ventricle. When this pressure is greater than the 
pressure in the aorta, the aortic valve opens, allowing blood to flow through the aortic 
valve as seen in Figure 3. Upon the end of ventricular systole, the pressure in the 
ventricle rapidly drops, and the higher aortic pressure causes the aortic valve to close.  
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Figure 3. Flow path of blood through the left side of the heart [9]. 
 
 
 
Wigger’s diagram (Figure 4) is a common chart used to describe the cardiac cycle 
and the activity of the valves. Left atrium, aortic, and left ventricular pressures are plotted 
over time, and the interactions among these pressures determine the mitral and aortic 
valve state. In the diagram, the ventricular pressure rises just before systole during a 
period called isovolumic contraction. During isovolumic contraction, both the mitral and 
aortic valves are closed, so when the left ventricle contracts, pressure increases while 
volume does not. At the point where the ventricular pressure overcomes the aortic 
pressure, the aortic valve opens. This causes the aortic pressure to rise alongside the 
ventricular pressure. The ventricular pressure remains above the aortic pressure during 
systole, until the left ventricle contraction concludes. When the ventricular pressure 
crosses the aortic pressure on its decline, the aortic valve closes at the dicrotic notch. 
Isovolumic relaxation occurs when both the mitral and aortic valves are closed. After this 
notch, the aortic pressure slightly rises again as blood rushes back towards the aortic 
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valve for a small portion of time. Wigger’s diagram illustrates the ideal pressure 
waveform shape, highlighting the systolic and diastolic components.  
 
 
 
 
Figure 4. Wigger’s Diagram [10]. 
 
 
 
Diseased Valve States 
Valves can suffer from many diseases for a variety of reasons, and one example 
of a diseased valve state that commonly affects the aortic valve is aortic stenosis. Aortic 
stenosis prevents proper blood flow from the left ventricle to the aorta during systole. 
Due to this restriction, the pressure differential across the valve increases, causing larger 
stress on the left ventricle as it tries to overcome an increased afterload and force blood 
through the aortic valve. Over time, this over-working of the left ventricle can cause a 
decrease in the efficiency of systolic function. Aortic stenosis is one of the most common 
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valve diseases that plagues cardiac patients and presents a need for aortic valve 
replacement, and an exemplary image of stenosis can be found in Figure 5. 
 
 
 
 
Figure 5. Exemplary image of a stenotic aortic valve when it is closed and open. The stenotic state 
prevents full closing and opening of the valve, contributing to left ventricle load increase. 
 
 
 
Another valve diseases, aortic regurgitation, occurs during ventricular diastole 
when blood unintendedly flows from the aorta back into the left ventricular. In 
regurgitative states, the pressure differential to fully close the valve is not achieved; 
therefore, blood from the forward stroke volume regurgitates back into the left ventricle. 
Aortic pressure decreases, and there is an increase in preload due to this leakage. Like 
aortic stenosis, aortic regurgitation causes increased stress on the left ventricle and can 
lead to systolic issues over time. 
Valve Replacement 
 Aortic stenosis or regurgitation can be corrected using drugs, balloon 
valvuloplasty, valve repair, and surgical procedures that increase blood flow or correct 
for leakage. In patients with severe valve disease, replacements may be the only option. 
Further developments in valve replacements will greatly assist this patient cohort in need 
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of valve replacement. In 1952, the first valve replacement was conducted by Hufnagel, 
leading to the now 170,000 replacements annually in the US [2].  Valve replacements 
typically fall into two categories: mechanical and bioprosthetic. Exemplary images of 
valve types over the past sixty years can be found in Figure 6. 
 
 
 
 
Figure 6. Exemplary images of the different valve designs over the past sixty years. The McGovern-
Cronie valve is a mechanical, ball-in-cage valve. The Bjork Shiley Delrin valve is a mechanical, tilting disk 
valve. The Medtronic Open Pivot valve is a mechanical, bi-leaflet valve. The Biocore Aortic Valve is a 
surgical, bioprosthetic valve. Lastly, the Edwards Sapien 3 valve is a bioprosthetic, transcatheter valve 
[11, 12].  
 
 
 
Mechanical valves are a more durable option for valve replacements. The most 
popular of the mechanical valves is the bi-leaflet valve, and it has two leaflets connected 
by a hinge joint to a metal annulus. Mechanical valves are generally made of pyrolitic 
carbon. Although mechanical valves are superior in durability, they have more issues 
surrounding biocompatibility [13]. Mechanical valve patients must use blood thinners to 
prevent blood clots because the valve geometry has the tendency to introduce turbulent 
flow [2].  
McGovern-Cronie
Bjork Shirley Delrin
Medtronic
Open Pivot BiocoreAortic Valve
Edwards 
Sapien 3
ley elrin
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Bioprosthetic valves utilize porcine or bovine pericardial tissue to form the valve 
leaflets. In 1970, first bioprosthetic valve, the Hancock valve, was introduced. These 
valves have since been widely developed and include leaflets sewn onto a metal or 
polymeric ring. Stented and transcatheter valves are currently being further developed, 
which allows for a larger orifice area due to their lack of structural annulus. Bioprosthetic 
valves are good alternatives to mechanical valves because of their similarities to the 
native valve; however, issues with durability can pose problems. Due to their native 
nature, bioprosthetic valves can succumb to the natural degenerative effects of the body 
and end up experiencing regurgitation and calcification. 
Bioprosthetic and mechanical valves provide good options for patients in need of 
valve replacements, and their shortcomings are well-known. Development of an ideal 
valve that is durable while maximizing biocompatibility will propel this research field to 
the next level.  
Motivation 
Worldwide, cardiac disease is growing rapidly, and diseased valve conditions 
contribute to the growing number. High blood pressure (HBP) and other coronary heart 
diseases (CHD) like myocardial infarction, chest pain, heart failure, and stroke are some 
common disease states, with over 80 million people affected by high blood pressure and 
15.5 million affected by CHD [1]. When heart valve malfunction occurs, proper blood 
flow is disrupted which can have negative effects on the heart. Heart valve disease 
prevalence increases with age, with the highest cohort of people affected over 75 years of 
age [1]. Two of the most common diseased valve states are regurgitation and stenosis. 
Generally, stenosis occurs when the valve fails to open fully, restricting the amount of 
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flow through the orifice. Regurgitation occurs when the backflow prevention mechanism 
of the valve is not operating correctly and results in retrograde flow back through the 
valve. 
The prevalence of valvular heart disease increases with age [14]. Approximately 
2.8% of elderly individuals suffer from moderate or severe aortic stenosis (AS), and 2.0% 
suffer from moderate or severe aortic regurgitation [1]. These two conditions can provide 
opportunity for valve replacements. 40% of those patients with severe AS will undergo 
aortic valve replacement [1]. As the number of patients with cardiovascular disease 
continues to increase, so does the demand for valve prostheses. Prior to implantation, new 
valve designs need to be validated experimentally. 
Criteria for evaluating these valve replacements prior to clinical implantation 
through the use of pulse duplication are specified in the ISO (International Standards 
Organization) 5840:1:2015 - Cardiovascular implants – Cardiovascular valve 
prostheses. The testing inputs reported by these guidelines aim to test the valve under 
worst-case conditions at various pressure states. The guidance documents are “living” 
standards that are still being developed, based on the progression of the field; however, 
all valve manufacturers adhere to the criteria. Pulse duplicators are systems that can be 
used to perform this standard testing. A variety of pulse duplicators are available for 
academic and commercial use. However, there are limitation for both categories of 
systems, leading to the need for custom, benchtop systems in 3rd party laboratories.  
Existing Solutions 
Pulse duplicators are used in valve research during the design phase to experiment 
with different components and investigate which components of the valve may lead to 
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complications like hemolysis or thrombosis. Development of a pulse duplicator that 
accurately simulates the cardiac environment is essential for the growth of the heart valve 
replacement field. Use of pulse duplicators can assist in furthering valve research related 
to clinical symptoms; therefore, multiple labs have developed their own pulse duplicators 
to analyze newly designed valves and also investigate historical issues associated with 
each valve type. A variety of pulse duplicator designs have been published, and each of 
them have a slightly different goal or emphasized measurement parameter. Some labs 
have produced pulse duplication systems that simply simulate flow and do not take into 
account native geometries while others have mimicked human geometry closely. Across 
the board, there are common features seen in most left heart pulse duplicators: a 
component or chamber representing the left ventricle, left atrium, and aorta, compliance 
and resistance portions, optical clarity, reservoirs, circulatory loops, flow and pressure 
measurement tools, and a driving pump. 
 The most physiologically relevant designs include a circulatory loop, while other 
simulators can be extremely simplified to only focus on one part of the valve 
performance, like back flow pressure, choosing to neglect native components. Bjork, et 
al. designed one of the preliminary pulse duplicators in 1956 for evaluation of prosthetic 
aortic and mitral valves in different conditions, and a schematic can be seen in Figure 7 
[3]. Their system utilized a roller pump to supply stroke volume at the desired 
systolic/diastolic ratio. The system was divided into a pumping portion and testing 
system. The testing side included a left ventricle component (elastic bag), aortic 
component (rubber tube) and left atrium component (open reservoir), with two valves 
housed in chambers with pressure transducers connected to them [3]. Changing the 
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resistance by adjusting the screw clamps and changing the pressure head applied by the 
reservoir allowed the system to be tuned to simulate different cardiac environments [3]. 
The components that make up Bjork’s pulse duplicator laid the foundation for standard 
component pieces seen in successful pulse duplicators that followed. 
 
 
 
 
Figure 7. Schematic of Bjork’s left heart simulator [3]. The pump system was a roller pump that supplied 
stroke volume to the system. The left ventricle was an elastic bag housed in a plastic container, and the 
pressure transducers were connected to the mitral and aortic housing. The resistance was adjusted 
downstream of the aorta using screw clamps. 
 
 
 
 More recently, Yoganathan’s Georgia Tech lab has developed multiple left heart 
simulators, and a schematic of the Yoganathan-FDA system can be seen in Figure 8. The 
LHS has two rigid chambers representing the left ventricle and left atrium. A mitral valve 
fixed to a silicone ring using Dacron separates the two chambers from one another [5]. 
Pressures and flows can be measured from the set up while the pulsatile flow is delivered 
using a compressible bladder pump that is connected to the left ventricle [5]. The LHS 
includes multiple compliance and resistance portions in the form of syringes and gradual 
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on/off gated valves, respectively [5]. This specific pulse duplicator includes the use of 
two chambers to represent the left ventricle and left atrium and is specifically fixtured in 
order to retain the native mitral valve attachment points during testing [15, 16].  
 
 
 
 
Figure 8. Schematic of Yoganathan’s left heart simulator [5]. The pulsatile flow is driven by a 
bladder pump attached to the left ventricular chamber. The papillary muscle holders are used as a fixture 
for the mitral valve attachments. Resistance and compliance components can be seen in the on/off valves 
and syringes, respectively. A flow probe is placed upstream of the mitral valve, and pressure transducers 
measure the left ventricular and left atrial pressure. 
 
 
 
Kheradvar’s academic lab at the University of California, Irvine has published a 
dual valve design that utilized a thin-walled ventricle, shaped using molds from a systolic 
ventricle. The ventricle floats freely inside of a fluid filled clear container that is attached 
to a Vivitro Superpump (a hydraulic pump system), as seen in Figure 9 [17]. The 
Superpump is a piston-in-cylinder actuator that is operated by an electric motor [17, 18]. 
The combination of the silicone ventricle, the Superpump, and the clear container 
provides the driving mechanism for the left heart system and allows simulation of the 
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cardiac cycle [17]. The natively mimicked ventricle contains both an aortic and mitral 
valve, and the complete system includes a reservoir, resistors, and a pressure regulating 
valve. 
 
 
 
 
Figure 9. Schematic of Kheravdar’s left heart simulator. The system is driven by the Vivitro Superpump 
and a silicone molded ventricle housed in a clear, fluid filled chamber. A reservoir, pressure regulating 
valve, high speed camera, flow probes, and pressure transducers are incorporated in the design.  
 
 
 
 Commercial pulse duplicators include the Vivitro Labs Pulse Duplicator, 
Dynatek’s MP3 Pulse Duplicator, and BDC Labs Left Heart Simulator. These pulse 
duplicators can be seen in Figure 10. Each of these designs are slightly different, offering 
the user a more automated system, but the addition of automation can sacrifice the 
amount of control and types of valves that can be tested. BDC laboratories produced the 
HDT-500 Pulse Duplicator System, driven by BDC’s pulsatile pump, which complies 
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with ISO 5840 and can be configured for use with mitral and aortic valves. The Vivitro 
Labs Pulse Duplicator meets the ISO requirements and uses its own pulsatile pump and 
anatomically mimicked ventricle to generate flow through valves placed in its Model Left 
Heart and allows the user to modify resistance and compliance. Lastly, the Dynatek MP3 
Pulse Duplicator allows application of pulsatile flow with full visibility. This design 
allows resistance changes to be made with clamps and compliant tubing and utilizes a 
programmable pumping system.  
 
 
 
 
Figure 10. Example images of the three commercial pulse duplicators discussed in this paper. 
 
 
 
While there are many left heart simulators used to evaluate prosthetic valves, 
there is room for improvement in both academic and commercial settings. The 
commercial pulse duplicators lack the ability to be flexible, to simulate pathological 
conditions, and to keep up with the constantly changing field. They are designed with the 
current valve designs in mind. On the other hand, the academic pulse duplicators are 
always on the cutting edge of technology. However, the constant turn around in grad 
students can cause knowledge to be lost between students. Grant funding also dictates the 
BDC Dynatek ViVitro
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use of equipment, so if there is no funding, it is likely that the pulse duplicator will be 
abandoned or a low priority. In addition, there is little to no quality control in academic 
labs which could lead to data errors. The disadvantages of both groups of pulse duplicator 
leads to the need of a custom pulse duplicator for 3rd party pre-clinical evaluation of 
prosthetic valves in standardized laboratory environments.  
Purpose of the Study 
 Pulse duplication tester testers have proven to be an effective way to evaluate 
heart valve replacements based on guidelines stated by the ISO 5840. Heart valve 
development requires the use of pulse duplication to properly assess valves prior to 
clinical implantation, and the construction of in-house pulse duplicators with the ability 
to be tuned and modified depending on valve type can assist in quickly advancing this 
field of research. Having a custom pulse duplicator would allow quality control, 
standardization of testing procedures, and flexibility in testing capabilities and the 
adaptation to market needs. The purpose of this study is to develop and validate a left 
heart simulator for evaluating aortic, bi-leaflet mechanical valves in a 3rd party, 
preclinical setting with the goal of expanding the capabilities of the system to test a range 
of valve designs and types. The system will be validated based on criteria specified by 
ISO 5840.  
 
Specific Aim I: Design of Left Heart Simulator 
The first specific aim in this study revolves around the design of a left heart 
simulator to test mechanical, aortic heart valves. The simulator will be evaluated based 
on criteria from ISO 5840 and literature. 
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Methods: Design Process 
The foundation of the design process for the pulse duplicator was rooted in ISO 
5840 as well as components popularly seen in commercial and published pulse 
duplicators. These components were compiled and used as a foundation for the initial 
design iteration. Each design iteration was built and tested, and then modifications were 
made in order to achieve the outstanding parameters of the ISO criteria. The design 
iterations can be found in Appendix I: Design Iterations. Some of the early design 
iterations were simulated computationally. During the testing portion for each of the 
designs, the criteria were revisited, and components were modified in order to resolve 
issues and remove obstacles preventing the achievement of the design goals. The goal of 
the design was to build an in house left heart simulator using a novel driving mechanism. 
A custom pulse duplicator to be used for 3rd party prosthetic valve testing is crucial for 
pre-clinical laboratories because it allows modifications to be made to the system, quality 
control, adaptability to client needs, and standardization of procedures. The final design 
was a dual valve left heart simulator design centered on testing aortic mechanical valves, 
with the use of a tissue valve as the mitral valve.  
ISO 5840 and Literature Guidelines 
Criteria for pulse duplication are specified in the ISO (International Standards 
Organization) 5840:1:2015 – Cardiovascular Implants. The testing inputs reported by 
these guidelines aim to test the valve under worst-case conditions at various pressure 
states. Scientific and clinical data are used to determine accurate parameters. The FDA 
suggest the use of ISO 5840:1 to evaluate the performance of prosthetic valves. The 
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guidance documents are “living” standards that are still being developed, based on the 
progression of the field.  
ISO does not provide comprehensive details for pulse duplication of valves, but it 
does present basic criteria to use as a foundation that is helpful when building a pulse 
duplicator. A specific test duration is not established by ISO, but at least 10 cardiac 
cycles must be measured. In those ten cycles, multiple variables can be measured 
including peak diastolic pressure differential, aortic pressure ranges, and percent duration 
of forward flow [6]. In addition, the guidelines specify additional parameters that 
describe the cardiac environment: typical cardiac outputs, systolic and diastolic duration 
percentages for a normal heart, and heart rates. ISO specifies a normal cardiac output 
range to be from 2-7 L/min, with the average occurring at 5 L/min [6]. The ISO 
guidelines give a range of typical heart rates at 30-200 beats per minute and typical stroke 
volumes at 25-100 mL. Specific aortic pressure ranges are presented to accurately 
represent different cardiac environments, and for a healthy patient, the aortic range 
should be from 80 mmHg to 120 mmHg. The systolic and diastolic percentage of cardiac 
cycle is defined to be 35% and 65%, respectively, for normotensive, 5 L/min, 1.17 Hz 
testing conditions.  
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Figure 11. Pressure plot of two cardiac cycles with the ventricular pressure waveform plotted in blue, and 
the aortic pressure waveform plotted in red. The ventricular waveform should have a rapid rise (green) and 
rapid fall (purple), as well as be close to zero during diastole (red circle) because there is little pressure 
build up. The aortic pressure wave form should slowly decrease during diastole (orange). The dicrotic 
notch and the intersection of the ventricular and aortic waveform that occurs when the valve opens should 
be visible. 
 
 
 
ISO provides ideal pressure waveforms for users to compare to during pulse 
duplication, and a representation of these waveforms can be seen Figure 11. There are a 
few important characteristics to note about the aortic and left ventricle pressure 
waveforms. The ventricular waveform rises and drops quickly with the rapid opening and 
closing of the aortic valve. The diastolic portion of the left ventricle should be as close to 
zero as possible and maintain a flat shape. The aortic pressure crosses the ventricular 
pressure as the aortic pressure begins to rise because this is the location at which the 
aortic valve opens and allows fluid to pass into the aorta. The aortic valve shuts when the 
aortic pressure is above the left ventricular pressure, and there should be a dicrotic notch 
at that location. Post-dicrotic notch, the aortic pressure rises slightly as some retrograde 
flow occurs before the aortic valve shuts. The aortic pressure should decrease slowly 
during diastole to reach 80 mmHg (for normotensive conditions).  
Rapid Rise
Rapid Fall
Aortic Valve Opens
Dicrotic NotchSlow Decrease
 23 
ISO defines the diastolic peak differential pressure in Equation 2 where EDP is 
aortic end diastolic pressure, and PSP is aortic peak systolic pressure. EDP is the pressure 
found during the intersection of the aortic and ventricular pressure as the valve opens. 
PSP is the maximum pressure achieved by the aorta during systole. The location of these 
parameters during the cardiac cycle can be visualized in Figure 12. The peak differential 
pressure for the normotensive, health case is 100 mmHg.  
 
 
 
Equation 2. Peak diastolic differential pressure equation where EDP is end diastolic pressure, and PSP is 
peak systolic pressure. 𝑃𝑒𝑎𝑘	  𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑖𝑐	  𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡𝑎𝑙	  𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 = 𝐸𝐷𝑃 + 12 (𝑃𝑆𝑃 − 𝐸𝐷𝑃) 
 
 
 
 
Figure 12.Visualization of EDP and PSP on the cardiac cycle. The end diastolic pressure is the aortic 
pressure at the end of diastole where the aortic valve opens, the aortic peak systolic pressure occurs at the 
maximum aortic pressure during systole, and the valve shuts at the dicrotic notch at the aortic end systole 
pressure. 
 
 
 
The ISO guidelines define the percentage of the cardiac cycle that systole and 
diastole comprise for normal conditions (5 L/min, 70 bpm, normotensive) to be 35% and 
Aortic Peak
Systolic Pressure
!"#$%&'()'*#$%&'( = 3565
Aortic End
Diastolic Pressure
(valve opens)
Aortic End 
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(valve shuts)
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65%, respectively. As heart rate increases, the systolic percentage of the cycle increases. 
With this systolic time breakdown, the systolic percentage of the cardiac cycle as a 
function of heart rate can be calculated by taking the systolic time and dividing it by the 
total time in the cycle in milliseconds (for example, 854 milliseconds for a frequency of 
1.17). The diastolic percentage can be found by subtracting the systolic percentage from 
100. The systolic/diastolic ratio refers to the time portion of the cardiac cycle that makes 
up systole divided by the time portion of the cardiac cycle that makes up diastole. A full 
summary of the parameters dictated by the ISO guidelines for a healthy individual can be 
found in Table 1. 
 
 
 
Table 1. ISO parameters for testing as described in the guidelines for a normotensive, healthy individual. 
Cardiac Output 5 L/min 
Heart Rate 70 bpm (1.17 Hz) 
Stroke Volume 70 mL 
Systolic/Diastolic 35 / 65 
Differential Pressure 100 mmHg 
Aortic pressure range 80-120 mmHg 
 
 
 
Criteria and Constraints 
 The criteria primarily stem from the guidelines set by ISO 5840, but a few criteria 
originate from a literature review of pulse duplication and common features seen in those 
systems.  
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The first criterion was sufficient motor capacity and control, in the form of 
actuator displacement. The driving mechanism behind the pulse delivered to the system 
must be supported by a motor that has frequency and displacement control and that can 
operate at 1.17 Hz and ± 4.4 mm to simulate the correct cardiac output for a health state. 
The motor must be driven by an external program that allows the achievement of the 
necessary systolic and diastolic ratios. The motor displacement must match the motor 
command within 10% at the necessary frequencies and displacements. 
The second criterion is repeatability. The pulse duplicator must be able to produce 
the same pressure responses in the system accurately over fifteen continuous cycles once 
steady state has been reached. The standard requires ten continuous cycles of testing. The 
mean standard deviation among all these cycles should be less than ± 5 mmHg, as some 
variability is expected due to the noise associated with a mechanical valve closure [19, 
20]. Next, the aortic valve must be able to be viewed during testing with good optical 
clarity for imaging, and the valve must open and close properly (no fluttering).  
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Table 2. Table of the criteria for the project established from literature and ISO 5840. 
Summary of Criteria Criterion Acceptance Criteria 
Heart Rate 1.17 Hz 1.17 Hz 
Cardiac Output 5 L/min 4.75 – 5.25 L/min 
Actuator Displacement 4.4 mm 3.96 – 4.85 mm 
Systolic/Diastolic Ratio 35/65 percent 
31.5 – 38.5 / 58.5 – 71.5 
percent 
Peak Diastolic Differential 
Pressure 
100 mm Hg 95 – 100 mmHg 
Aortic Pressure Range 80 – 120 mmHg 75-85 to 115 – 125 mmHg 
Pressure Waveform Qualitative analysis Qualitative analysis 
Repeatability 
Mean STDEV < 5 
mmHg 
Mean STDEV < 5 mmHg 
Valve Performance Qualitative analysis Qualitative analysis 
 
 
 
 Lastly, the design must sufficiently simulate the left heart’s cardiovascular cycle 
as represented by pressure waveforms. To evaluate this criterion, the ISO guidelines will 
be used. As described previously, the system must be able to produce a cardiac output of 
5 L/min, which is considered an average cardiac output for normal patients with a heart 
rate of 70 beats per minute. This criterion will be tied to motor performance, and the 
cardiac output must be within 5% of 5 L/min. The systolic/diastolic ratio is defined by 
ISO (for the 70 beats per minute condition). The systolic and diastolic ratios measured 
experimentally must fall within less than 10% of the tabulated values. ISO aortic pressure 
ranges must be met. Next, the pressure waveforms must mimic the ideal shape seen in 
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Figure 12, and the significant components of the shape of the sinusoidal curve must be 
maintained (as discussed in ISO 5840 and Literature Guidelines). The last criterion is that 
diastolic differential pressure must be met. The ISO guidelines provide the foundation for 
the criteria for this project; however, pressure measurements (aortic pressure ranges and 
differential pressure) within ± 5 mmHg of the ISO guidelines are generally accepted by 
cardiovascular researchers. A summary of the criteria associated with this project can be 
found in Table 2.  
 There are constraints associated with this project. The first constraint is budget. 
Monetary restraints play a large role in this project due to the number of expensive 
components required to conduct pulse duplication: driving mechanisms, custom 
machining, flow sensors, pressure transducers, high speed imaging, etc. Due to this 
monetary constraint, there will be no flow sensors used in the project, and the pulse 
duplicator was rigidly designed (no anatomically mimicking compartments) because of 
the costly nature of those vessels, and prosthetic tissue valves cannot be acquired. The 
use of a mechanical valve due to valve availability and price as well as durability of the 
valve to withstand multiple design iterations, testing, and validation will also limit the 
results. Next, a time constraint is dictated by the thesis defense date of April 25 which 
requires all testing to be done multiple weeks prior to that date. The project also requires 
that the design be flexible and tunable and compliant with the ISO guidelines. The 
constraint of the choice of motor is dictated by the frequency and displacement needed to 
conduct a pulsatile flow, and lastly, the valve should be able to be fully visualized during 
testing.  
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Design Decision Matrix 
 A summary of the utilized motors and design iterations can be found in Table 3 
and Table 4. Further details on the design iterations can be found in Appendix I: Design 
Iterations Motor. Performance was rated on a scale of 1 to 5 based on the capacity of the 
motor to complete the actuator command. The LM1 motor was not a feasible choice for 
this iteration of the pulse duplicator due to its limited displacement abilities and load 
capacity. The motor did not have the capacity to reach the displacement command set by 
the user. The modification from the vertical to horizontal orientation of the LM1 did not 
improve the LM1 performance. The MTS actuator has a larger displacement range and 
increased capacity for load which resulted in achievement of the displacement command 
while testing. The comparison between the command and output can be seen in Figure 13 
for the MTS motor at a frequency of 1.17 Hz and cardiac output of 5 L/min. 
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Figure 13. Plot of actuator displacement output (blue) and actuator command (red) over time in 
millimeters. There is an innate lag between the command and output waveforms. However, the actuator 
displacement closely matches the actuator command. 
 
 
 
Table 3. Decision matrix for choice of motor to use in left heart simulator. 
Motor Displacement Performance Comments 
LM1 Vertical ± 6.5 mm 1 
Displacement output does not 
match command 
LM1 
Horizontal 
± 6.5 mm 2 
Displacement output does not 
match command 
MTS Actuator ± 50 mm 5 
Displacement output matches 
command 
 
 
 
Table 4 illustrates the decision matrix to compare the various design iterations 
based on the ISO criteria. The designs were rated by performance on a scale from 1 to 5. 
Some criteria were not evaluated during the design iteration process due to the immediate 
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need to modify other essential portions of the design. Those scenarios are marked with an 
“n/a.” Descriptions of these designs can be found in Appendix I: Design Iterations. 
 
 
 
Table 4. Decision matrix table for design iterations. Design A and B utilized the LM1 motor and the TA 
Electroforce Durapulse Chamber C was only computationally simulated. Design D and the final design 
were built using the MTS load frame actuator. 
Criteria A B C* D Final 
Heart Rate 1 2 n/a 4 5 
Cardiac Output n/a n/a n/a n/a 5 
Actuator Displacement 5 5 5 5 5 
Systolic/Diastolic Ratio 1 2 2 3 5 
Peak Diastolic Differential 
Pressure 
n/a n/a n/a n/a 5 
Aortic Pressure Range 2 2 3 5 4.5 
Pressure Waveform 1 1 1 1 4 
Repeatability 1 1 3 3 5 
Valve Performance 3 3 5 5 5 
*Never conducted experimentally 
 
 
 
The design matrix table demonstrates the superior performance of the final design 
in comparison with the other design iterations with regards to the project criteria. 
 
Aim 1 Results 
 Aim 1 revolved around the ability to design a pulse duplicator that fit the criteria 
set previously in this paper. The design process culminated in the final design of the left 
heart simulator through the use of the decision matrix and criteria and constraints. The 
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final design included the use of multiple components seen in both literature and 
commercial pulse duplicators including a left ventricle, driving mechanism, viewing 
window, compliance and resistance components, and reservoir. The final design utilized 
the MTS actuator as its driving mechanism to deliver pulsatile flow through PVC piping, 
and the pressure of the left ventricle and aorta were measured over time with pressure 
transducers (location noted in Figure 14 with stars). Schematics of the final design can be 
seen in Figure 14 through Figure 15. The valves are housed in the left ventricle and can 
be visualized in Figure 15. Engineering drawings of the custom machined pieces of the 
set up can be found in Error! Reference source not found.. 
 
 
 
 
Figure 14. Isometric view of the SolidWorks rendering of the final design of the left heart simulator. The 
direction of flow is indicated with red arrows. The cylindrical left ventricle, the viewing window, reservoir, 
compliance chambers, and resistance valves can be seen. 
 
 
 
**
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Figure 15. Schematic of the final design of the left heart simulator with labeled components. 
 
 
 
The fluid in the system follows a circulatory path. Initially, the actuator is 
commanded to pull back, mimicking systole, and the mitral valve opens due to the higher 
left atrial pressure generated by the atrial pressure head as compared to the left 
ventricular pressure. Fluid passes through the atrial resistance and atrial compliance 
components prior to entering the left ventricle. Fluid flows into the left ventricle through 
the mitral valve, representing diastole. The pressure in the left ventricle is lower than the 
pressure in the aortic portion of the system, keeping the aortic valve shut. Once filling is 
complete, the actuator pushes the bellow forward, generating higher pressure in the left 
ventricle and opening the aortic valve. The aortic resistance and compliance play a role in 
the aortic valve opening and the pressure waveforms during systole. The fluid flows out 
through the aortic valve and then through compliance and resistance components, 
completing the loop by emptying into the atrial reservoir.  
Left Ventricle
Bellow and actuator
Atrial Compliance
Atrial
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Aortic 
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There is an atrial pressure head built into the system to simulate the resting 
pressure found in the left atria. The atrial pressure head is calculated using Equation 3 
where 𝜌 is the density of the fluid in kg/m3 (water), g is the acceleration due to gravity 
(9.8 m/s2), and h is the height in meters. The height measurement is made from the center 
of the mitral valve to the height of the fluid in the reservoir and is 0.3 meters. This height 
provides an atrial pressure head of 20 mm Hg as seen in Figure 16. This atrial pressure is 
slightly higher than what is seen in vivo, but is limited by the length of the on/off valve. 
 
 
 
Equation 3. Hydrostatic pressure equation used to calculate the pressure head. 𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 = 	  𝜌𝑔ℎ 
 
 
 
 
Figure 16. Atrial pressure head height measurement is made from the center of the mitral valve to the 
height of the fluid in the reservoir. 
 
 
 
h=30cm
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In addition, there is a pressure compensation that has to be added to the pressure 
measurements made in the left ventricle due to the height offset between the aortic and 
left ventricular pressure transducers. Using Equation 3, this pressure compensation was 
calculated to be 6 mmHg and was added to all of the left ventricular pressure readings. 
The height measurement can be seen in Figure 17. 
 
 
 
 
Figure 17. Pressure compensation measurement for the left ventricle. 
 
 
 
Left Ventricle 
The left ventricle is a cylindrical chamber machined out of acrylic that is 0.2 
meters in diameter and 95 millimeters long, as seen in Figure 18. The ventricle allows 
attachment to the driving mechanism (the actuator and bellow) through the use of piping 
and houses two valves: the mitral and aortic valve. The ventricle has pockets that fit a 
valve holder in which the aortic and mitral valve are fixtured. The size of the ventricle 
was machined to just fit the two valve holders. The valve holders press fit into the 
Pressure transducer
h
 35 
pockets in the ventricle, allowing installment of two valves of varying sizes and designs. 
The left ventricle has two pipes attached to it. One pipe receives fluid from the left 
atrium, and the other pipe allows the ventricle to eject fluid to the aorta. The left ventricle 
has two luer ports, one at the top and one at the bottom. The top luer port can house a 
pressure transducer and is used to purge the ventricle of air, and the bottom luer port is 
used as a draining port. The left ventricle can be broken down by unscrewing the bolts 
found in a circular pattern around the circumference of the chamber. Removal of the 
circumferential screws is the only detachment point required to install or change valves. 
 
 
 
 
Figure 18. Experimental photo of the left ventricle. The left ventricle receives fluid through the mitral 
valve, and then the fluid is ejected to the aorta by the actuator and bellow. 
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Valve Holder and Fixturing 
 The valves are fixtured in a rectangular valve holder and press fit into the left 
ventricle. The valve holder was designed by TA Electroforce for use with the TA 
Electroforce Durapulse. The valve holder is an acrylic case measuring 60 x 70 
millimeters with a 54 millimeter diameter recess surrounded by many orifice holes. The 
diameter of the valve holder limits the size valve that can be tested using this valve holder 
to be less than 0.054 meters; however, new valve holders can be easily machined to fit 
any valve. A white slip is placed over the valve and secured with four bolts to keep the 
valve in place. Depending on the type of valve, the valve can be fixtured in many 
different ways. Mechanical valves can be press fit into silicone rubber cored to fit their 
exact diameter as seen in Figure 19. Tissue valves can be sutured into the cored silicone 
rubber using surgical sutures, as was done with the tissue valve used in the mitral location 
for this set up, seen in Figure 19.  
 
 
 
 
Figure 19. Image of the mechanical and tissue valve in the valve holder. The diameter of the valve holder is 
54 mm. Both valves sit in silicone rubber that was cored to fit their diameters. The mechanical valve was 
press fit into the rubber, and the aortic valve was sutured. 
 
 
Diameter – 54mm
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Compliance 
Compliance is required in a pulse duplication system to mimic the elasticity found 
in the native vessels, which allows them to contract and dilate depending on the fluid 
volume. In a rigid system, compliance is essential to the achievement of relevant pressure 
waveforms. Two compliance chambers are used in this system: aortic and atrial. Both 
chambers have luer ports in the top in order to add or bleed air. An aortic compliance 
chamber is found downstream of the aortic valve, and it is 0.3 meters tall and has a 
diameter of 0.127 meters, as seen in Figure 20. The chamber simulates the native 
compliance of the aortic vessels, and without compliance here, the aortic valve would 
unnaturally slam shut. Compliance provides a slight cushion and reduces this closing. 
The compliance can be modified by changing the amount of air in the cylinder. The 
addition of more air is correlated with an increase in compliance. An increase in 
compliance causes a reduction in the aortic pressure wave amplitude. Therefore, when 
tuning the system, the amount of aortic compliance can be adjusted to achieve the desired 
aortic pressure range.  
The second compliance chamber is the atrial compliance, found upstream of the 
mitral valve. It has a diameter of 25.4 millimeters and is 0.14 meters tall, as seen in 
Figure 20. The atrial compliance mimics the compliance of the left atrium and assists in 
tuning of the left ventricle waveform. The addition of compliance can decrease the noise 
associated with the diastolic pressure waveforms of the cardiac cycle and assist in 
lessening the effect of the rigidity of the left ventricle. Compliance chambers play a large 
role in an otherwise rigid system which allows the production of relevant pressure 
waveforms. 
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Figure 20. Aortic and atrial compliance components in the left heart simulator. The red circles highlight 
the luer ports on the top of each chamber that allows air to be added and bled. 
 
 
 
Resistance 
Resistance components in the left heart simulators are found in the form of one-
way PVC gradual on/off valves (McMaster Carr, 97865K33), as seen in Figure 21. These 
valves allow flow in one direction through a gated channel that can be manipulated by 
closing or opening the valve manually, which are ideal for incremental tuning. There are 
two resistance components in the system: atrial resistance and aortic resistance. The atrial 
resistance component regulates the amount of flow that is able to reach the mitral valve 
by gating the amount of fluid leaving the reservoir. The atrial resistance affects the 
diastolic portion of the left ventricle. The less atrial resistance, the more flow reaches the 
mitral valve, causing the ventricular pressure wave to shift up. The more atrial resistance, 
the less flow reaches the mitral valve, causing the ventricular pressure to shift down. 
Aortic 
Compliance
Atrial 
Compliance
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Atrial resistance allows manipulation of the left ventricular pressure and gates flow to the 
rest of the system.  
The aortic resistance component is found downstream of the aortic valve and 
aortic compliance. It mimics the decrease in vessel diameter as flow crosses the aortic 
valve and the total peripheral resistance of the body driven by the arterioles. Pressure is a 
function of area, and natively, when the diameter of the aorta is smaller than that of the 
left ventricular, there is resistance to the flow of blood into the aorta, increasing aortic 
pressure and in turn, ventricular pressure. Therefore, the addition of aortic resistance will 
shift the aortic pressure curve upwards, while the decrease of aortic resistance will shift 
the aortic pressure curve downwards. 
 
 
 
 
Figure 21. Representative image of the resistance component of the pulse duplicator. In this case, this is 
the atrial resistance. 
 
 
 
Reservoir 
 The reservoir in this design is a 1.5 gallon graduated bucket with a PVC pipe 
connection (McMaster Carr, 8993T43). The reservoir is 0.19 x 0.18 x 0.17 meters and 
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simulates the left atrium, as seen in Figure 22. Because the system only simulates the left 
heart, fluid ejected out through the aortic valve empties into the left atrium; however, 
physiologically, the aorta is pushing blood to the rest of the body. The left atrium 
supplies blood to the left ventricle, as is mimicked in the set up. The fluid must pass 
through the resistive and compliance portions before reaching the mitral valve. As 
discussed previously, the height of the reservoir simulates the pressure head of the atrium 
that is relatively constant in the cardiac cycle. In order to ensure that no air bubbles are 
being introduced to the system through the reservoir, the pipe outlet hole must always be 
covered with water. The left atrium pressure head can be adjusted by increasing and 
decreasing the amount of water in the reservoir. More or less water may need to be added 
to the system depending on the heart rate being tested. For this research, the atrial 
pressure head was always maintained at 20 mm Hg. 
 
 
 
 
Figure 22. Image of the reservoir in the experimental set up. Flow leaves the reservoir and fills the left 
ventricle, and ejected fluid returns back to the reservoir. 
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Pulsatile Pump 
 The driving mechanism in the left heart simulator is a combination of an MTS 
MiniBionix 858 load frame actuator and a bellow adapted from the TA Electroforce Stent 
Graft Tester, as seen in Figure 23. The actuator housing is mounted vertically to the test 
set up, and the actuator piston is connected to the closed side of the bellow through an 
M12 to 10-32 screw adapter. The actuator sits underneath of the bellow. The bellow is 
housed in a 316SS casing connected to an interface plate. The bellow is responsible for 
ejecting fluid to the left ventricle. The bellow is closed on one end and open on another, 
with the open end having a diameter of 0.1 meters. The bellow is 0.14 meters long at 
resting length and can safely expand to the maximum needed displacement for testing. 
The bellow was mounted vertically so that air bubbles could be bled from the top through 
a luer port. 
  
 
 
 
Figure 23. Images of the bellow (left) and MTS actuator (right). The bellow is adapted from the TA 
Electroforce tester. 
 
 
 
Actuator
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The actuator is driven by servo hydraulic power and is operated using an MTS 
TestStar controller and Test Suite software. Actuator movement is dictated by user inputs 
of frequency and displacement. The actuator has a displacement range of ± 50 mm and 
can run up to 25Hz. The actuator ran a custom waveform profile for this project. The 
waveform was comprised of two concatenated cosine waves that were scaled based on 
their systolic or diastolic durations of the cardiac cycle. The systolic and diastolic cycle 
durations that were used to create the pump waveforms were drawn from the ISO 
guidelines.  
 Due to the lack of flow probes accessible for this project, cardiac output was 
estimated based on bellow size and actuator displacement. The actuator waveform was 
not only scaled by frequency, but also displacement, in order to reach an estimated 
cardiac output of 5 L/min. Cardiac output was estimated using Equation 1, assuming 
stroke volume can be estimated by a cylinder volume. The cylinder volume was 
calculated by multiplying the area of the bellow by the length of displacement of the 
actuator, described in Figure 24. The amplitude of the actuator waveform would be 
scaled to ± ½ of the required displacement based on the function of the load frame. For 
normotensive, healthy conditions, the required total displacement of the actuator is 8.8 
mm. 
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Figure 24. Cardiac output estimation formula and measurement locations. The cardiac output was 
estimated using the total displacement of the actuator and the area of the bellow. 
 
 
 
Pressure Transducers 
 Two pressure transducers (MPR-500 Mikro-Tip®, Millar, Houston, TX) were 
used in this set up to measure ventricular and aortic pressure over time, and the locations 
of these sensors can be seen in Figure 26. The pressure transducers are low profile, 
reusable, diffused semiconductors that interface with the PCU-2000 control unit which 
can connect to the MTS controller via BNC cables. The size 5F, polyurethane catheters 
were initially calibrated using a three-point calibration process and a digital multimeter 
(Fluke 15B+ Multimeter). The pressure transducers are then calibrated to correct for drift 
before each testing day using the PCU-2000 control unit. An image of the catheter and 
control box can be seen in Figure 25. 
 The MPR-500’s have a pressure range of -50 to 300 mmHg and function using +/- 
5 volts of excitation. Their sensitivity is 5 μV/V/mmHg, and they drift less than 3mmHg 
in 24 hours, after being zeroed in water. The frequency response of the catheters is flat to 
10kHz. 
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Figure 25. Representative image of the MPR 500 catheter and the PCU-2000 pressure unit box. 
 
 
 
 
Figure 26. Placement of the ventricular and aortic pressure sensors. The measurement location is 
illustrated by the red circles. 
 
 
 
Viewing Window 
 Optical clarity is essential for the evaluation of prosthetic valves during pulse 
duplication. This system utilized a 0.05 x 0.05 meter clear, acrylic box attached 
downstream of the aortic valve in order to record videos and images of the valve, and 
images of the viewing window can be seen in Figure 27.  
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Figure 27. Experimental images of the viewing window. The left image displays a lateral view of the 
viewing window where the arrow illustrated the direction that the camera would face. The middle image 
displays the location of the viewing window in the overall set up. The right image displays an example of 
the image that can be captured of the aortic valve using the viewing window. 
 
 
 
Tuning Process 
 The components that can be tuned in the system are the aortic compliance, atrial 
compliance, atrial resistance, and atrial compliance. Frequency and actuator displacement 
can also be changed, but these values were predetermined by the desired testing 
conditions for this project. In addition, the height of the water and the height of the 
reservoir relative to the center of the valve can be modified for further testing, but these 
components stayed constant. The first step in tuning is to tune the aortic waveform. The 
aortic waveform drives the ventricular waveform, so, after the aortic portion has been 
tuned appropriately, the ventricular pressure will generally follow suit. The tuning 
process starts with the adjustment of aortic resistance, then compliance. The aortic 
resistance will shift aortic resistance up and down while the aortic compliance will 
change the amplitude of the aortic wave. The aortic pressure was tuned in order to reach a 
range of 80 mmHg to 120 mmHg. Then, the ventricular pressure was tuned. Changing the 
atrial resistance would affect the diastolic portion of the ventricular pressure curve and 
modifying the atrial compliance would adjust the shape of the ventricular pressure curve 
during the rising phase. The Compliance and Resistance sections provide more specifics 
Viewing
Direction
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on how changing the resistance and compliance of the system can modify the waveforms. 
Tuning was considered completed when the aortic ranges were met and the overall shape 
of the waveforms was accurate.  
Aim 1 Discussion 
 Three constraints were maintained during Aim 1: system flexibility, motor 
capacity, and valve visualization. Optical clarity was achieved with the addition of the 
viewing window. Due to the construction with acrylic, the viewing window has good 
visibility and is large enough to capture videos or images of the valve while the tester is 
running. Next, the addition of the two on/off valves as well as the two compliance 
chambers enables incremental and controlled compliance and resistance modifications on 
both sides of the system that can be used for tuning. Lastly, the use of the MTS load 
frame enabled the required frequencies and displacements to be achieved. The first aim 
was completed, and the next aim details on the validation of the design. 
 
Specific Aim II: Validation of Design 
The goal of the validation study was to evaluate the performance of the left heart 
simulate in regards to the quantitative criteria that were set. In order to validate the 
design, a normotensive test was run at 1.17 Hz using an aortic, mechanical valve. The 
valve was fixtured to the valve holder, placed in the left ventricle, and the system was 
tuned. The test was run for at least 15 cycles with a data acquisition frequency of 1024 
Hz. The pressure and displacement data were output as a text file from the MTS Test 
Suite Program and subsequently analyzed in MATLAB (MATLAB 2015b, The 
MathWorks Inc., Natick, MA). 
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Methods 
A summary of the validation testing inputs can be found in Table 5. Although the 
field is heading towards development of bioprosthetic valves, a 25 millimeter diameter 
mechanical valve was chosen for this validation procedure because of its durability and 
accessibility by the lab. The system was tuned to compensate for the stiffness of the 
mechanical test valve. Images of the bi-leaflet mechanical valve that was used for testing 
can be seen in Figure 28. The mechanical valve was press fit into a silicone ring in order 
to be installed in the valve holder. 
 
 
 
Table 5. Summary table of the testing inputs for validation. The heart rate, cardiac output, and fluid were 
used to mimic normal in vivo conditions. 
Heart Rate (Hz) 1.17 
Cardiac Output (L/min) 5 
Mitral Valve Porcine tissue valve 
Aortic Valve Bi-leaflet mechanical valve 
Fluid Phosphate buffered saline solution 
Pressure State Normotensive 
Duration 15 Cycles 
Systolic/Diastolic 35/65 
Aortic Pressure Range 80 – 120 mmHg 
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Figure 28. Digital microscopic image of the mechanical valve used for testing. The top images display the 
aortic side of the aortic valve while the bottom images display the left ventricular side. 
 
 
 
 For the mitral valve selection, an aortic porcine tissue valve was used. The 
porcine tissue valve was 25 millimeter in diameter and was excised from a full grown 
porcine heart. The valve was then sutured to a silicone ring in order to be installed in the 
valve holder. An image of the excised tissue valve can be seen in Figure 29. 
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Figure 29. Image of the porcine tissue valve sutured to the silicone ring. It is a 25 mm diameter native 
aortic valve. 
 
 
 
Analysis Methods: Qualitative and Quantitative 
 Once testing was completed, the data was exported from the MTS Test Suite 
Program, brought into MATLAB and filtered using a moving average with a span of 5 
data points. The pressure waveforms from the ventricular and aortic chambers were the 
data sets of interest. In order to evaluate whether the system functions appropriately, the 
experimental measurements and observations were compared to the previously set 
quantitative and qualitative criteria. The quantitative measurements that were made from 
the pressure waveforms after data collection were the aortic pressure ranges, the systolic 
and diastolic duration ratios, and the peak diastolic differential pressure. N = 15 
measurements were made on 15 consecutive cycles. In addition, in MATLAB, the 
repeatability of the system was evaluated by taking the average and standard deviation of 
the ventricular and aortic pressure waveforms over 15 cycles. The qualitative criteria that 
were evaluated were the shape of the pressure waveforms, valve performance, the optical 
clarity of the system, and the ability to tune the system. 
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Aortic Pressure Range and Peak Differential Pressure Measurement Method 
 The aortic pressure range measurements were made by making 15 measurements 
of the minimum and maximum pressures of the aortic wave over 15 consecutive cycles. 
The minimum aortic pressure (A) was found at the end of diastole (aortic end diastolic 
pressure, Figure 12) using the findpks command in MATLAB. The maximum aortic 
pressure (B) and the end systolic pressure (C) were found after the aortic valve opens at 
the peak of systole (aortic peak systolic pressure, Figure 12) using an interactive gui and 
the ginput command in MATLAB. The repeatability of these manual maximum pressure 
measurements was validated by the low standard deviation over the 15 waveforms (seen 
in Aortic Pressure Range). The first peak of the aortic wave was chosen due to the 
subsequent peaks suffering from oscillations. Both the maximum and minimum 
measurements were then separately averaged across 15 cycles and standard deviations 
were calculated. The averages were compared to the ISO guidelines for the aortic 
pressure range for normotensive conditions (80 mmHg – 120 mmHg) and the peak 
diastolic differential pressure (100 mmHg, Equation 2).   
 
 
 
  
Figure 30. A few cardiac cycles are plotted over time. The blue line is the aortic pressure wave and the red 
line is the ventricular pressure wave. A, B, and C are locations on the graph that are important for the 
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calculation of the aortic pressure range and the peak differential pressure. A is the End Diastolic Pressure, 
B is the Peak Systolic Pressure, and C is the End Systolic Pressure. The image of the left includes the 
ventricular waveform, and the image on the right contains just two cardiac cycles and only the aortic 
waveform. 
 
 
 
Systolic and Diastolic Ratios Measurement Method 
 The systolic and diastolic ratios were measured using an overlaid graph of the 
aortic and ventricular pressures for 15 consecutive cycles, and an average and standard 
deviation of the 15 measurements were reported. The averages were compared to the ISO 
guidelines systolic/diastolic ratio (35/65). The systolic portion of the cardiac cycle is 
defined as the time during the cardiac cycle that the aortic valve is open (time in A). The 
systolic percentage was calculated by dividing the systolic time by the period of the test 
which was 0.854 seconds (time in B). The diastolic ratio was found by subtracting the 
systolic ratio from 1.  
 The time at which the aortic valve opens is the intersection of the ventricular and 
aortic pressure following diastole. The public MATLAB code InterX was used to identify 
the intersection time. The time at which the aortic valve closes occurs at the dicrotic 
notch, more clearly seen in Figure 12. This location was chosen manually due to the 
noise surrounding a mechanical valve shutting. The repeatability of this manual 
measurement procedure was validated by the standard deviation over the 15 waveforms 
(seen in Systolic and Diastolic Ratio). The mechanical valve closure is generally known 
to experience a noisy closure due to its rigid material composition [19].  
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Figure 31. Representative image of the measurement locations for the aortic valve opening (red circle) and 
aortic valve (purple circle) closing. The difference in the time at these two points represents the systolic 
time period. A is the time in one systolic duration, and B is the time in one complete cardiac cycle 
 
 
 
Repeatability Assessment Method  
 To assess the repeatability of the tester, the average and standard deviation of 15 
consecutive cycles for both the aortic and ventricular pressures were taken in MATLAB 
by using the length of one cycle (854 milliseconds for a frequency of 1.17 Hz). The 
average cycle was plotted over time with the standard deviation results overlaid as error 
bars. An example of the separation of the cycles that were averaged can be found in 
Figure 32. 
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Figure 32. Representative image of five cardiac cycles over time. In the repeatability assessment, 15 of 
these cycles were separated based on the distinction in this image, averaged, and the standard deviation 
was calculated. 
 
 
 
Motor Capacity 
 The motor capabilities were assessed by comparing the actuator command 
displacement waveform at 1.17 Hz and a displacement of ± 4.4 mm to the output 
displacement waveform. 
Other Assessment Methods 
 The shape of the pressure wave was analyzed. As mentioned in the ISO 5840 and 
Literature Guidelines section, the aortic and ventricular pressures must rise in systole and 
fall during diastole. The aortic pressure must gradually fall during diastole after the aortic 
pressure rises above the ventricular at the dicrotic notch and start to rise once the 
ventricular pressure crosses the aortic pressure. The ventricular pressure must stay close 
to zero during diastole and rise and fall quickly. The ventricular pressure must stay above 
the aortic during systole. 
1 2 3 4 5
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 Valve performance was observed. This can be evaluated by ensuring that the 
valve is opening and closing, without fluttering, and that the valve remains open for the 
entirety of systole and closed for the entirety of diastole. 
Aim 2 Results  
The results of the normotensive, 1.17 Hz pulse duplication testing using the left 
heart simulator can be seen below. Each quantitative measurement was taken over 15 
consecutive cycles (n=15). 
Valve Performance  
A representative video of the aortic valve can be seen in Figure 33. As described 
in Figure 40, despite the pressure waveform oscillations, the aortic valve stays completely 
open during systole. In addition, the valve cleanly opens and closes. There is no fluttering 
throughout the cycle. The valve does not slam shut and functions properly. The valve 
performance criterion is achieved.  
 
 
 
 
 
 
 
 
 
Figure 33. Video recording of the aortic valve through the viewing window during the normotensive, 1.17 
Hz validation testing.  
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Aortic Pressure Range 
 The aortic pressure range data for the normotensive, 1.17 Hz validation test can 
be found in Figure 34. For normotensive pressure waveforms, the ISO guidelines suggest 
an aortic pressure range of 80 to 120 mmHg. During the validation testing, an aortic 
pressure range of 79 ± 0.33 to 129 ± 0.36 mmHg was measured using the methods 
described in the Aortic Pressure Range and Peak Differential Pressure Measurement 
Method section. The cardiovascular field generally accepts pressures that are within ± 5 
mmHg of the ISO guidelines. For the end diastolic pressure (the aortic range minimum), 
the pressure criteria were achieved. For the peak systolic pressure (aortic range 
maximum), the pressure criteria were not achieved. However, due to the large ranges of 
cardiovascular pressure seen in vivo, the pressure ranges still accurately represent a 
normotensive patient [21]. Regardless, the maximum aortic pressure range criterion 
technically was not met for the normotensive validation system. The main source of this 
error most likely lies in the rigidity of the test system. With a more rigid system, large 
pressure measurements are easily obtained because the vessels and chambers do not 
dilate and expand due to an increase in volume of fluid. With the introduction of more 
volume comes the increase in pressure. Most of this rigidity could be compensated for 
with addition of compliance chambers; however, the combination of the mechanical test 
valve and rigid ventricle creates an environment where even the large compliance 
chamber could not counteract the increasing pressure. In future improvements on this 
design, a silicone ventricle will be added to the setup which will reduce the rigidity and 
allow the top pressure aortic pressure range to be attained (as seen in Design 
Limitations). In addition, the extremely low standard deviations for both EDP and PSP, 
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display the repeatability of the tester and measurement method over 15 cycles. The aortic 
pressure ranges measured from the system represent a healthy, normotensive individual’s 
aortic pressure at resting heart rate. 
 
 
 
 
Figure 34. The normotensive aortic pressure range measurements results (in mmHg) include the end 
diastolic pressure (EDP) and the peak systolic pressure (PSP) for both the experimental (blue) and ISO 
specified criteria (red). The plotted experimental data describes the average and standard deviation (n=15) 
of the EDP and PSP measurements. 
 
 
 
Systolic and Diastolic Ratio 
 The systolic and diastolic percentages of the cycle for the normotensive, 1.17 Hz 
validation test can be found in Figure 35. The systolic percentage was measured to be 37 
± 0.59, and the diastolic percentage was measured to be 63 ± 0.59 for the normotensive 
validation test over 15 consecutive cycles. The criteria require the systolic and diastolic 
percentages to be within 10% of the desired valves; therefore, the system accurately 
achieves the systolic and diastolic ratio criteria. The left heart simulator simulates the 
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timing of systole and diastole in the cardiac cycle for normotensive, 1.17 Hz validation 
test. 
 
 
 
 
Figure 35. The systolic and diastolic percentage measurements are plotted for both the experimental (blue) 
and ISO specified criteria (red) for the normotensive condition. The plotted experimental data describes the 
average and standard deviation (n=15) of the systolic and diastolic percentages.   
 
 
 
Peak Diastolic Differential Pressure 
 The peak diastolic differential pressure for the normotensive, 1.17 Hz validation 
test can be found in Figure 36. The peak differential pressure was found to be 104 ± 0.24, 
which is within ± 5 mmHg from the criteria of 100 mmHg. Therefore, the differential 
pressure criterion was achieved for the normotensive condition regardless of the higher 
end maximum aortic pressure range.  
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Figure 36. The normotensive differential pressure measurements (in mmHg) are plotted for the both the 
experimental (blue) and ISO specified (red) criterion. The plotted experimental data describes the average 
and standard deviation (n=15) of differential pressure.   
 
 
 
Repeatability 
 The average and standard deviation of 15 consecutive cycles for both the aortic 
and ventricular pressure waveforms can be seen in Figure 37 for the normotensive, 1.17 
Hz validation test, and the average and maximum standard deviation of these data are 
tabulated in Table 6. The average pressure waveform displays good repeatability of the 
system to produce the aortic and ventricular pressure waveforms over time for the 
majority of the cycle. The error surrounding the closure of the mechanical valve is 
expected, and its behavior cannot be controlled by the system. The addition of 
compliance to the system may aid to decrease the error surrounding this area, but the 
cardiovascular field accepts this mechanical valve closing behavior and its effects on the 
pressure waveforms. While the maximum standard deviations across the entire waveform 
are high, the mean standard deviation more accurately represents what is occurring. The 
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maximum standard deviation describes the aortic valve closing; however, the majority of 
the waveform has little error associated with it. Therefore, the repeatability criterion was 
attained by the tester because both the aortic and ventricular waveforms had a mean 
standard deviation of less than ± 5 mmHg over 15 consecutive cycles (1.4 and 0.98, 
respectively).  
 
 
 
 
Figure 37. The average aortic and ventricular pressure waveforms (n=15) plotted over time for the 
normotensive, 1.17 Hz validation test. The standard deviation of each portion of the cycle can be seen in 
the shaded blue and red color, mostly clustered at the valve closure area. 
 
 
 
Table 6. The average and maximum standard deviation for the aortic and ventricular pressure waveforms 
over 15 cycles for the normotensive, 1.17 Hz validation test. 
Standard Deviation Aortic (mmHg) Ventricular (mmHg) 
Average 1.4 0.98 
Maximum 22.3 8.6 
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Motor Capacity 
 The motor response for the normotensive, 1.17 Hz validation test is plotted in 
Figure 13. The lag between the command and output is expected and an innate feature of 
using servo-hydraulic motors. The actuator displacement is also plotted in Figure 38. The 
actuator displaced ± 4.35 mm in the experimental set up. To obtain a cardiac output of 5 
L/min, the required actuator command displacement range is ± 4.4 mm for 1.17 Hz. To 
compare the experimental and ideal cardiac outputs, Equation 1 was used to calculate the 
experimental cardiac output. The experimental actuator displacement results in 4.9 
L/min. The displacement waveform accurately mimics the command waveform; 
therefore, the motor capacity is sufficient to run the pulse duplicator under these normal 
conditions. 
 
 
 
 
Figure 38. The actuator displacement for the normotensive, 1.17Hz test is plotted over time. The minimum 
and maximum displacement values in millimeters are shown with arrows on the graph. 
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Pressure Waveform Analysis 
The ventricular and aortic pressure waveforms are plotted over time for a 
representative portion of the test and seen in Figure 39. There are a few key features of 
the waveform to discuss. Overall, both waveforms rise during systole and fall during 
diastole. As previously discussed, the aortic pressure waveform has a range of 79 to 129 
mm Hg, and it gradually decreases during diastole. The ventricular maximum follows a 
similar systolic pattern, but the ventricular waveform rises and drops sharply, which 
mimics the native ventricular activity. In addition, the aortic and ventricular pressures 
cross prior to the rise of the aortic pressure, when the aortic valve opens. The waveforms 
additionally display a dicrotic notch which is followed by a rapid decrease in the 
ventricular pressure after the aortic valve closes. The ventricular waveform stays 
relatively close to zero for the majority of diastole, and the maximum peaks of the 
ventricular waveform are above the aortic pressure for systole. 
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Figure 39. Consecutive ventricular and aortic pressure waveforms over time for the normotensive, 1.17 Hz 
validation testing. 
 
 
 
The general shape of the pressure waveforms mimics the expected cardiovascular 
cycle seen in vivo. However, there are some portions of the design that can be improved 
upon. A large peak in the aortic pressure wave can be seen at the end of systole. This 
peak is audibly supported by patients who have had mechanical replacements and note 
the “clicking” sounds coming from their valves when it opens and closes. The noise 
associated with this valve activity is popularly seen in mechanical valve pressure 
waveforms and is deemed an innate characteristic of the valve. Additionally, although the 
systolic portion of both pressure waves has oscillations, through the use of still images 
captured from video recordings, it can be concluded that the aortic valve remains open 
for the entirety of systole. Therefore, the effects of the oscillations on the aortic valve’s 
performance are insignificant. Figure 40 displays the valve status over one entire cardiac 
cycle. Note that during systole, the aortic valve is captured as open, and during diastole, 
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the aortic valve is closed. However, these oscillations limit accurate pressure wave 
measurements made in this time period, so improvements to the design are necessary. 
 
 
 
 
Figure 40. Plot of ventricular and aortic pressure over time with the addition of valve images at each time 
point of interest. The still images of the valve were taken during diastole, aortic valve opening, systole, and 
aortic valve closing to confirm that during the entirety of systole, the aortic valve remained open regardless 
of the pressure oscillations. 
 
 
 
Additionally, the conclusion that the oscillations seen in the waveforms do not 
cause the valve to open and close over systole but rather, stay open, can be supported 
through video analysis of the systolic duration. Using the MATLAB functions read and 
imagesc, the video recorded from the experimental tests can be broken into frames. From 
these frames, the number of frames in a cardiac cycle was determined. The number of 
frames while the valve was open (systole) was found to be 36% of the total number of 
frames in the cardiac cycle. Therefore, the oscillations seen in the pressure waveforms do 
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not seem to affect the systolic portion of the cardiac cycle because the systolic/diastolic 
ratio is maintained. Possible causes of these oscillations will be discussed in the Design 
Limitations section. 
The other portion of the waveform that could be improved upon is the ventricular 
pressure during diastole. While the curve rises and drops sharply, the pressure has a slight 
slope before it starts to rapidly rise. This characteristic likely is due to the rigidity of the 
left ventricle, seen clinically as well [22]. The increase of atrial compliance did eliminate 
the majority plateau in the ventricular waveform. However, the rigidity of the system 
prevents its complete removal, and implementation of a more compliant system will 
improve the diastolic portion of the ventricular waveform. Clinically, patients with stiff 
left ventricles, like the rigid ventricular chamber in this system, have the same ventricular 
pressure response as seen in the experimental pressure waveforms (Figure 41). Overall, 
the general shape of the pressure waveforms accurately mimics in vivo conditions; 
however, improvements can be made to remove the oscillations and slight rise in 
ventricular pressure. The qualitative criteria of accurate pressure waveforms are partially 
achieved. 
 
 
 
 65 
 
Figure 41. Clinical ventricular pressure graph over time to display the irregular diastolic portion due to 
ventricular stiffness [22]. The red arrow points to a portion of irregularity. 
 
 
 
Aim 2 Discussion  
Efficacy of Design: Summary of Criteria  
 After the normotensive, 1.17 Hz validation testing, the efficacy of the left heart 
simulator can be summarized based on previously set criteria, seen in Table 7. The 
majority of the criteria were achieved in the design validation step. The aortic pressure 
range and pressure waveform shape criteria were partially attained during the validation 
study; however, future work will improve these conditions. Overall, the validation of the 
LHS demonstrated that mean cardiac parameters can be controlled during testing. 
Therefore, Aim 2 was completed with suggestions for future work. 
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Table 7. Summary table of the criteria after the completion of Aim 2 where an “x” dictates the attainment 
of the criterion, and an “P” dictates that a criterion has been partially achieved. 
Summary of Criteria Criterion Acceptance Criteria Achieved 
Heart Rate 1.17 Hz 1.17 Hz ✓ 
Cardiac Output 5 L/min 4.75 – 5.25 L/min ✓ 
Actuator Displacement 4.4 mm 3.96 – 4.85 mm ✓ 
Systolic/Diastolic 
Ratio 
35/65 percent 
31.5 – 38.5 / 58.5 – 71.5 
percent 
✓ 
Peak Diastolic 
Differential Pressure 
100 mm Hg 95 – 100 mmHg ✓ 
Aortic Pressure Range 80 – 120 mmHg 75-85 to 115 – 125 mmHg Partially 
Pressure Waveform 
Qualitative 
analysis 
Qualitative analysis Partially 
Repeatability 
Mean STDEV < 5 
mmHg 
Mean STDEV < 5 mmHg ✓ 
Valve Performance 
Qualitative 
analysis 
Qualitative analysis ✓ 
 
 
 
Design Limitations 
There were a few limitations of the design that can be addressed in future work. 
First, the pulse duplicator is designed to mimic the cardiac cycle with the addition of 
compliance and resistance portions that simulate the vessel compliance and diameter 
changes at different portions along the circulation path. However, the use of a rigid 
chamber had its limitations, especially when testing a mechanical valve, due to the 
reflection that can occur in the left ventricle when the valve opens and closes. As 
discussed, the opening and closing of the mechanical valve can cause a pressure wave to 
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be emitted, hit the wall of the rigid chamber, and bounce back towards the valve, 
continuing this pattern until the wave has lost energy. The use of an anatomically 
mimicked left ventricle will assist in limiting murmurs as well as dampening this 
reflection Figure 42 provides an example of the integration of a silicone ventricle in 
Bazan’s left heart simulator [20]. These anatomical ventricles maintain the left ventricle 
shape and are molded with a compliant material like silicone. The introduction of this 
ventricle into the system would require submersion of the ventricle into a fluid chamber. 
The pressure changes in the chamber as a result of actuator displacement will dictate the 
contraction and dilation of the ventricle and therefore, the delivery of the pulse to the rest 
of the system. In addition to this anatomical implementation, other portions of the cardiac 
pathway can be modified to be more physiologically relevant. For implantation of aortic 
valves, the aortic sinus can be mimicked, as seen in Figure 42, and like the molded left 
ventricle, components like the atrium can also be casted to native shape and compliance, 
removing the rigidity that the existing reservoir contributes to the system [23].  
 
 
 
  
Figure 42. The image on the left provides an example of a silicone, anatomical left ventricle that was 
used in Bazan’s pulse duplicator [20]. The image on the left provides an example of a molded aortic sinus 
used in a left heart simulator that was seen in Yap’s pulse duplicator [23]. 
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Next, the current pulse duplicator utilizes a native porcine aortic valve for the 
mitral side of the tester. This valve was chosen due to its availability and cost and was 
suitable for its role as a control valve because this study was focused on the aortic valve 
in the pulse duplicator. While the use of this valve is sufficient to create the desired 
pressure waveforms in the system, it may contribute to a negative pressure state 
depending on the desired cardiac output and frequency. While the actuator retracts, it 
pulls fluid in through the mitral valve, prior to its contraction and ejection of fluid 
through the aortic valve. If the actuator pulls back too far or too quickly in the existing 
system, a negative pressure may be created because of the small size of the mitral valve. 
Natively, the mitral valve is 1 to 2 prosthetic valve sizes bigger than the aortic valve. 
When the size distribution is not upheld, the end diastolic volume is less than desired 
because the mitral annulus size limits the amount of fluid that flows through it over time. 
During this scenario, the actuator may cause a small vacuum. In order to mitigate this 
situation, a prosthetic mitral valve should be substituted into the system that is 2 sizes 
larger than the aortic valve being tested. These mitral valves can be excised from human 
cadavers who have received prosthetic valve replacements. 
Another limitation of this system is the lack of experimental flow data due to the 
lack of a flow meter. The lack of flow rate data produced by this design is solely a 
product of monetary resource limitations and time. The reported cardiac output and flow 
waveforms calculated from the actuator displacement are estimations based on actuator 
displacement and bellow size, and the introduction of a flow meter into the system will 
require the testing matrix associated with this project to be re-run. The next steps in this 
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project include the implementation of flow sensors downstream and upstream of the 
aortic valve.  
Lastly, there were two sources of oscillations and noise in the pressure waveform. 
First, noise was observed at the end of systole (described by “1” in Figure 43), most 
likely due to the mechanical valve closure, as seen in literature. In addition, there were 
oscillations seen in the systolic portion of the cardiac cycle (described by “2”), as seen in 
Figure 43. These oscillations proved to not affect the activity of the valve in the video 
frame analysis; however, elimination of these oscillations is necessary to create an ideal 
cardiac wave or measure any parameters over the systolic portion of the valve like mean 
differential pressure. This limitation must be further investigated.  
 
 
 
 
Figure 43. Two unexpected oscillations are seen in the pressure waveforms. The image on the left 
represents the expected noise associated with the mechanical valve activity. The systolic oscillations on the 
right could be caused by an impedance mismatch in the system. 
 
 
 
A root cause analysis can be conducted to investigate the source of the systolic 
oscillations, as illustrated in Figure 44. First, the murmurs could potentially be a product 
1 2
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of the design of the bellow, where the compression and extension of the bellow is not an 
entirely smooth process. This hypothesis is difficult to evaluate outside of the test system. 
The addition of a silicone ventricle could assist in evaluating this possible source to 
eliminate the effect of the rigidity. It is also possible that the bellow is maximized 
mechanically. If the bellow is close to its compressed or expanded limit during these 
directional changes, it could cause the oscillations seen in the systolic portion. This 
theory was investigated at extremely low displacements that are well within the range 
that the bellow can function. The systolic oscillations were still observed. 
Pump discretization could also be a source of the oscillations. The majority of the 
oscillations occur close directional changes of the actuator. The actuator has a large 
capacity for displacement, so it is not close to maximizing its mechanical limit in these 
locations.  However, if the pump waveform that drives the actuator command is not 
discretized enough surrounding these changes in direction, the actuator may not be 
operating as smoothly as it could be due to lack of data points. The actuator displacement 
command and output do not display this noisy behavior, but the effect of this under-
discretization could be small, and simply magnified by the pressure readings. In order to 
test this theory, the pump waveform data could be more discretized around directional 
changes, and the pressure readings could be observed. 
 
 
 
 71 
 
Figure 44. Root cause analysis to investigate the source of the systolic oscillations. 
 
 
 
Alternatively, the murmurs could originate in the bellow-actuator interface where 
the connections between the actuator, bellow, and test system are not completely aligned. 
This cause was investigated by taking a closer look at the actuator displacement 
waveform without the bellow attached, which proved to be smooth. The connection 
between the actuator and bellow are tightly bolted and in line, as well. Further 
investigation into these connections will have to be done in order to eliminate them as 
originations of the oscillations, and redesign may be required. 
 The reflection of the pressure waves off of the ventricular chamber due to the 
rapid opening and closing of the valves in such a rigid environment could cause these 
oscillations. The opening of the aortic valve could cause a pressure wave to be sent to the 
backside of the left ventricle, reflect, and come back to the valve multiple times. To 
investigate this concept further, two tissue valves were installed into the tester in an 
attempt to eliminate some of the rigidity introduced by the mechanical valve, and the 
same oscillations were observed, although slightly dampened. It is possible that the 
design of the left ventricle is conducive to these reflections and that the elimination of the 
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mechanical valve was not enough to reduce rigidity. In order to mitigate this source, an 
anatomical ventricle will be installed in the future. 
Lastly, there may be an impedance mismatch in the system between the upstream 
(left ventricle) and downstream (aorta) portions of the design that is causing these 
hydraulic murmurs to occur. If this is the source of the oscillations, this would mean that 
the input impedance caused by the driving mechanisms is not sufficiently dampened by 
the downstream components in the system (aortic compliance chamber and aortic 
resistance). If these impedances are matched, signal reflection could be minimized. While 
the load delivered by the driving mechanism was not quantified, its effects continue in 
the form of pulsatile, oscillatory flow to the aortic compliance chamber. As the system 
operates, the level of fluid in the aortic compliance chamber oscillates up and down with 
the actuator, and continuously sloshes back and forth during the cardiac cycle due to its 
movement. The energy and load that is introduced by the actuator and the ventricle 
(especially because of its rigidity), is not dampened by the aortic compliance chamber, 
but rather, the chamber acts more like a spring that reflects the energy back towards the 
ventricle. These reflections could be read by the pressure transducers as the systolic 
oscillations. To attempt to match the impedances, additional resistance or capacitance 
could be added to the system. This way, the downstream components could absorb more 
of the energy that is introduced by the actuator. Downstream resistance can be increased 
using the existing aortic resistance component. Downstream compliance could be 
modified by increasing the size of the aortic compliance chamber, allowing more 
dampening to occur. In addition, to thwart the effect of the fluid movement in the 
chamber, a fine mesh could be added to the compliance chamber that would keep the 
 73 
fluid level stable during testing, contributing to an additional “dashpot” effect, allowing 
the chamber to absorb more energy without converting it to movement of fluid. 
Further testing will be required to identify this root cause, and action will be taken 
to eliminate the noisy portion of the waveform in future work. Each root cause theory can 
be further researched and testing can be conducted to determine the final source. 
SWOT Analysis 
The strengths of this design include the availability for user input. The system can 
be controlled by displacement and frequency of the actuator which is easily dictated by 
the user. The user can also adjust the compliance and resistance of the system to fit many 
sizes and designs of valves, even though in this study, only the 25 mm mechanical valve 
was investigated. The design of the left ventricle allows for testing of bioprosthetic, 
transcatheter, and mechanical valves because of its size. The valve outer diameter can be 
up to 54 mm. The system has an easy displacement and pressure collection system, and 
the data can be quickly analyzed in an external program like MATLAB. The motor 
capacity of the system allows the left heart simulator to achieve a large range of cardiac 
outputs and frequencies. In addition, due to the PVC construction of the system, parts can 
be easily modified, added, or removed. Lastly, the left heart simulator viewing window 
allows excellent visualization of the aortic valve during testing. The system attains many 
of the criteria that are set by the ISO guidelines and includes the popular components 
found in published left heart simulators. The advantage of this pulse duplicator is that it’s 
an in-house pulse duplicator built on the foundation of a load frame that has been 
thoroughly characterized, has good control, and has excellent capacity for this work. The 
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pulse duplicator does not act as a black box, but rather, allows the user to have control 
over each portion of the cardiac cycle. 
The weaknesses of the design are closely related to the limitations. The biggest 
improvement that can be made to the design is the limitation of the flow meter in order to 
eliminate the need to estimate cardiac output. Other weaknesses of the design include the 
rigidity of the left ventricle, the use of a small mitral valve as compared to the aortic 
valve, and the generation of oscillations in the systolic portion of the cardiac cycle. While 
the design does require future work, the foundation of the tester can be used as a tester to 
evaluate heart valves. 
The pulse duplicator provides a large opportunity to assist in the development of 
the rapidly growing heart valve field. While the trend towards bioprosthetic valves is 
growing, the validation of the tester using a mechanical valve provides a solid foundation 
from which to build on. Testing of a bioprosthetic valve and the utilization of an 
anatomical ventricle will likely eliminate some of the impedance issues seen in the 
validation of the tester using the mechanical valve. The development of the LHS provides 
the opportunity to be a part of the ongoing research surrounding prosthetic valve 
development.  
The largest threats that the design will face is the “living” characteristic of the 
ISO guidelines. Because the validation of heart valves is relatively new, the requirements 
for validation of the devices is still being explored and constantly changing. The threats 
of competition to this design are not extremely relevant because the design is focused on 
in-house use and not commercialization. 
 
 75 
Future Work 
 The first steps in future work will be to address the design limitation surrounding 
the design. The most critical limitations involve the source of the systolic oscillations, the 
implementation of a flow meter, as well as the use of an anatomical ventricle. The 
validation of the system will be completed when those two limitations are eliminated. 
Following that validation, the tester will be verified using a range of different 
valve types. The introduction of different sized bioprosthetic valves as well as 
transcatheter designs will require additional verification testing and will expand the 
capabilities of the tester. The introduction of transcatheter designs will require novel 
fixturing solutions in order to deploy the valves correctly. The fixturing solutions will 
require their own rounds of testing and trial and error. In addition, to implement a more 
anatomically relevant ventricle, and aortic sinus will be added to the aortic portion. 
Lastly, there will be work surrounding the simulation of the papillary muscles on the 
mitral side so that the tester can be used to evaluate mitral valve performance as well. 
 
Conclusion 
 With the increase prevalence in heart disease globally comes the increased need 
for innovative valve designs. New designs require evaluation, and the FDA points 
towards guidance documents found in ISO 5840:1:2015 to outline criteria for valves that 
undergo pulse duplication. There are currently two categories of pulse duplicators to be 
used by valve manufacturers: academic and commercial simulators. Each have their 
limitations, and the construction of a custom pulse duplicator allows standardization of 
testing procedures and flexibility to market needs. 
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Aim 1 outlined the construction of the custom pulse duplicator under the criteria 
and constraints determined for this project. The design successfully adhered to the 
constraints and provided a standardized, flexible test system for evaluation of aortic, 
mechanical prosthetic valves through the control of average parameters. 
Aim 2 involved the validation of the system under criteria set by the ISO standard 
and from the field literature. Although many of the criteria were achieved, future work is 
necessary to be able to achieve all the design criteria and resolve design limitations. 
Limitations to the design that contributed to lack of complete validation included the use 
of a mechanical valve, the use of a rigid ventricle, systolic oscillations, and lack of a flow 
meter. These limitations have been thoroughly detailed, and more research will be 
required to determine the source of the systolic oscillations. 
Overall, a custom pulse duplicator was designed to evaluate aortic, mechanical bi-
leaflet valves under pulsatile flow. Pressure measurements could be made, and mean 
parameters could be controlled. Future work is necessary to refine the function of the 
system; however, this pulse duplicator can be used for preliminary valve testing and 
observation of valve performance.  
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Appendix I: Design Iterations 
There were preliminary design iterations built prior to the completion of the final 
design as seen in Figure 45. Initially, the use of a BOSE LM1 motor in conjunction with 
a bellow adapted from the TA Electroforce Stent Graft Tester and a TA Electroforce 
Durapulse testing chamber were compiled (A). This set up failed to meet the project 
criteria for a vast majority of reasons with the most critical ones being the lack of motor 
capacity and generation of non-physiological pressure waveforms. The next design 
iteration oriented the LM1 motor horizontally in hopes of counteracting the force of 
gravity on the motor (B). This design iteration improved upon the first due to the addition 
of the reservoir as an adjustable component and the use of two chambers to simulate the 
left ventricle and aorta. However, the LM1 motor still did not meet the motor capacity 
criteria, the system was infiltrated by air bubbles due to chamber leakage, and the lack of 
a circulation loop prevented the achievement of physiologically accurate waveforms.  
 
 
 
 
Figure 45. Previous design iterations of the left heart simulator. Design A utilized the LM1 motor and TA 
Electroforce Durapulse chamber, Design B utilized the LM1 motor and the addition of a reservoir, and 
Design C was the simulated model that utilized the MTS load frame. 
A) B)
C)
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The next design iteration was never built, only computationally simulated (C). 
This design integrated the use of a circulation loop and the implementation of a new 
driving mechanism (the MTS load frame) that had higher load capacity. However, 
preliminary CFD using STARMCCM+ displayed that the systolic forward flow was 
causing a jet stream on the back wall of the aortic chamber, and the pull back of the 
actuator was causing the reservoir to act like a sink, meaning that the system was creating 
a vacuum (Figure 46). This CFD data set used a medium grade, trimmed, Cartesian mesh, 
assumed steady state, turbulent flow and defined the inlet as the bellow supplying water 
at 6 L/min. The outlet condition was defined as pressure at the top surface of the reservoir 
(0 mmHg). Velocity distribution and streamlines were the primary output of the analysis. 
 
 
 
 
Figure 46. Preliminary CFD results of design iteration C. The leftmost image is the forward flow during 
systole, and the rightmost image is the retrograde flow during diastole. 
 
 
 
Because of the CFD results, the next design iteration included a tube at the top of 
the aortic chamber to force the liquid up instead of against the back wall where it was 
causing turbulent flow as seen in Figure 47 (D). In addition, a compliance cap was added 
Velocity (m/s)
1.17E-6 0.26
Velocity (m/s)
4.48E-5 0.25
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that could be made of different materials in order to modify the compliance of the system. 
The MTS system was still used in conjunction with the bellow, and the viewing window 
size was increased. Preliminary CFD was conducted on this design to evaluate the jet 
stream issue. Through CFD, it was found that this design achieved a pressure differential 
of 100 mmHg across the closed valve and that the jet stream had been eliminated (Figure 
48).  
 
 
 
 
Figure 47. Design iteration D included the use of the MTS load frames and an added compliance portion. 
 
 
 
Distal and Proximal Chamber
Compliance Cap
Pump
Two Pressure Sensors
Valve Holder
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Figure 48. Preliminary CFD conducted for design iteration D that displays the reduction of the jet stream 
against the back wall. 
 
 
 
Design iteration D had its pitfalls in its ability to simulate relevant flow 
waveforms, most likely due to lack of circulation and the minimal adjustability of 
compliance and resistance. Therefore, the final design iteration required the 
implementation of these two components. 
  
Velocity (m/s)
4.48E-5 0.25
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Appendix II: Final Design Engineering Drawings 
 
 
 
Figure 49. CAD representation of the final design with designation number of all parts. For those 
parts that are found in multiple, only one representative component is labeled. 
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Table 8. Table summarizing the component details for the final system design.  
Designation 
Number 
Item Name Manufacturer 
Model 
Number 
Number of 
Parts 
1 
Motor Interface - 
Small 
Custom n/a 1 
2 Valve Holder Custom n/a 2 
3 Small Bellow Ta Electroforce Custom 1 
4 
Compliance 
Chamber: Aortic 
Custom n/a 1 
5 Flange Custom n/a 4 
6 Chamber_1 Custom n/a 1 
7 Chamber_2 Custom n/a 1 
8 Chamber Cap Custom n/a 1 
9 PVC Piping McMaster Carr 48925K93 1 
10 PVC Elbow McMaster Carr 4880K23 7 
11 Viewing Window Custom n/a 1 
12 On/Off Valve McMaster Carr 9762K33 2 
13 Reservoir McMaster Carr 8993T43 1 
14 PVC Tee McMaster Carr 4880K43 1 
15 Luer Fitting McMaster Carr 51525K236 6 
16 PVC Plug McMaster Carr 4880K844 1 
17 Chamber Case Custom n/a 1 
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